technetium tc 99m diphosphonate has been researched along with 24,25-dihydroxyvitamin d 3 in 1 studies
| Studies (technetium tc 99m diphosphonate) | Trials (technetium tc 99m diphosphonate) | Recent Studies (post-2010) (technetium tc 99m diphosphonate) | Studies (24,25-dihydroxyvitamin d 3) | Trials (24,25-dihydroxyvitamin d 3) | Recent Studies (post-2010) (24,25-dihydroxyvitamin d 3) |
|---|---|---|---|---|---|
| 230 | 10 | 16 | 816 | 33 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, C; Riis, B; Thomsen, K | 1 |
1 trial(s) available for technetium tc 99m diphosphonate and 24,25-dihydroxyvitamin d 3
| Article | Year |
|---|---|
Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women.
Topics: 24,25-Dihydroxyvitamin D 3; Alkaline Phosphatase; Bone Regeneration; Clinical Trials as Topic; Dihydroxycholecalciferols; Diphosphonates; Double-Blind Method; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; Middle Aged; Osteoporosis; Progestins; Radionuclide Imaging; Random Allocation; Technetium; Technetium Compounds | 1986 |